Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02463695
Other study ID # STH18541
Secondary ID
Status Recruiting
Phase N/A
First received May 28, 2015
Last updated June 2, 2015
Start date October 2014
Est. completion date August 2015

Study information

Verified date June 2015
Source Sheffield Teaching Hospitals NHS Foundation Trust
Contact Jemima Clarke
Phone +44114 226 5938
Email Jemima.calrke@sth.nhs.uk
Is FDA regulated No
Health authority United Kingdom: Research Ethics CommitteeUnited Kingdom: National Health Service
Study type Interventional

Clinical Trial Summary

The pathophysiology of vertigo is complex and usually requires specialist involvement. During the diagnostic process, patients commonly undergo tests which assess the integrity of the gaze and posture stabilisation mechanisms involving the inner ear (vestibular system), the visual systems and the subconscious neural pathways that interconnect them. Whilst these tests are useful they fail to provide information concerning the neural connections to the cortex and therefore neglect the perceptual aspects of disequilibrium.

At present the possibility of routine examination of these higher projections remains elusive as no practical alternatives to the expensive functional magnetic resonance imaging systems exist. However, recently a novel method of recording cortical vestibular evoked potentials (CVEPs) has been described.

CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded. The recent breakthrough is in the realisation that these responses also contain information from the balance organs and therefore are a direct measure of cortical processing of the vestibular inputs.

Current evidence shows that CVEPs are present in the normal population and absent in patients with no vestibular function. The primary aim for this study is to extend the patient cohort to include those who have a vestibular injury but retain residual function. Patients going through standard testing will have also have CVEPs on both ears providing seminal information into the effect of injury to the peripheral vestibular system on the cortical pathways. Furthermore, by following the cohort through their complete management pathway it will be possible to ascertain if the CVEP can be used to predict rehabilitation outcome success.


Description:

Ears with a vestibular deficit:

Patients referred to the tertiary ear nose and throat clinics as well otoneurological clinics at the Royal Hallamshire will be eligible for enrolment. The investigators aim to record data from 36 ears with vestibular dysfunction.

A) Patients will receive a consultation with an ENT Consultant or Registrar as per standard practice.

B) If the patient is deemed by the doctor to have an otoneurological cause for their symptoms then further audiovestibular testing and imaging will be arranged as per standard practice. The patients will then be made aware of this study and if interested will be given the opportunity to discuss it further with the chief investigator (CI) or the principal investigator (PI).

C) If agreeable the patients will be given information packs by the PI/CI and taken through the study.

D) The patients will leave the consultation with the information pack and be asked to consider participation in the study. They will have no obligation to take part and they can contact the any member of the research team to ask for further information or to have any questions answered.

E) Upon their return for audiovestibular testing the patients will inform the CI/PI if they wish to participate in the study and if so will have an additional test at the end of test sequence. This will add approximately 30 minutes to their appointment time.

F) Patients who are suitable for rehabilitation (as per standard care pathway) will go ahead and have the course of treatment at subsequent visit(s). The outcomes following the treatment will be logged and correlated with the CVEP to check for any correlation that may or may not be present.

Otologically normal ears:

Normative data will be collected from 36 normal ears from subjects that have no history of audiovestibular symptoms and are not being investigated for any balance disorders. Healthy controls will be recruited via poster advertisements and potential participants asked to contact the research team if they are considering taking part.


Recruitment information / eligibility

Status Recruiting
Enrollment 51
Est. completion date August 2015
Est. primary completion date August 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Vestibular deficit Group:

1. Over 18 years of age

2. Can provide informed consent

3. Deemed to have an otoneurological cause for their symptoms (true vertigo, room spinning even when head is still)

4. No middle ear pathology

NORMATIVE GROUP:

1. Over 18 years of age

2. Can provide informed consent

3. No previous otoneurological history

Exclusion Criteria:

- VESTIBULAR DEFICIT GROUP PATIENTS

1. Participants under the age of 18

2. Participants unable to provide informed consent

3. Patients not deemed to have an otoneurological cause for their symptoms

4. Patients with middle ear pathology

NORMATIVE GROUP:

1. Previous history of problems with hearing and or balance

2. Participants under the age of 18

3. Participants unable to provide informed consent

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Procedure:
cortical vestibular evoked potentials (CVEPs)
CVEPs utilise an existing method used to interrogate cortical projections from the auditory system in which sound waves stimulate the inner ear and the resulting electrical responses from the brain are recorded (known as Cortical Auditory Evoked Potentials CAEPs)

Locations

Country Name City State
United Kingdom Sheffield Teaching Hospitals NHS Trust Sheffield South Yorkshire

Sponsors (1)

Lead Sponsor Collaborator
Sheffield Teaching Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary The degree of change of cortical vestibular evoked potential measured by amplitude (in microvolts) 6 months No
Secondary The time interval between the stimulation and response (latency) of cortical vestibular evoked potential 6 months No
See also
  Status Clinical Trial Phase
Completed NCT00271791 - Prednisone Treatment for Vestibular Neuronitis Phase 2
Completed NCT01943955 - Home-based Computer Gaming in Vestibular Rehabilitation N/A
Not yet recruiting NCT05424302 - Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy N/A
Terminated NCT02912182 - Acute Unilateral Vestibulopathy and Corticosteroid Treatment Phase 4
Completed NCT00411216 - Recovery of Visual Acuity in People With Vestibular Deficits N/A
Completed NCT00032383 - Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System Phase 1/Phase 2